GIMOTI, an FDA-approved nasal spray, is seeing expanded patient access through Omnicell and strategic support from EVERSANA.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GIMOTI, an FDA-approved nasal spray, is seeing expanded patient access through Omnicell and strategic support from EVERSANA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
Coverage
Newest first; wire copies grouped- GlobeNewswireEvoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship Separately Secures Access to OneGI Through Brentwood Pharmacy Agreement Gim